Modification of the telomerase gene with human regulatory sequences resets mouse telomeres to human length
Fan Zhang, De Cheng, Kenneth I. Porter, Emily A. Heck, Shuwen Wang, Hui Zhang, Christopher J. Davis, Gavin P. Robertson, Jiyue Zhu,
Dec 2025,
In: Nature communications
Date: Dec 2025
Managing telomerase and telomere dysfunction in acral melanoma
Vishnu Sravan Bollu, Yu Chi Chen, Fan Zhang, Krishne Gowda, Shantu Amin, Arun K. Sharma, Todd D. Schell, Jiyue Zhu, Gavin P. Robertson,
May 2025,
In: Pharmacological Research
Date: May 2025
Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity
Yu Chi Chen, Christopher G. Bazewicz, Saketh S. Dinavahi, Nicholas D. Huntington, Todd D. Schell, Gavin Robertson,
Apr 1 2025,
In: Molecular cancer therapeutics
Date: Apr 1 2025
Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting Subpopulations
Venugopal Vangala, Yu Chi Chen, Saketh S. Dinavahi, Krishne Gowda, Nazir A. Lone, Meenhard Herlyn, Joseph Drabick, Klaus Helm, Jiyue Zhu, Rogerio I. Neves, Arun K. Sharma, Arthur Berg, Marco Archetti, Shantu Amin, Todd D. Schell, Gavin P. Robertson,
Nov 8 2024,
In: ACS Pharmacology and Translational Science
Date: Nov 8 2024
Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor
Krishne Gowda, Asif Raza, Venugopal Vangala, Nazir Ahmad Lone, Jyh Ming Lin, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Todd D. Schell, Gavin P. Robertson, Shantu Amin, Arun K. Sharma,
Jul 2024,
In: Molecules
Date: Jul 2024
Pharmacological agents targeting drug-tolerant persister cells in cancer
Yu Chi Chen, Krishne Gowda, Shantu Amin, Todd D. Schell, Arun K. Sharma, Gavin P. Robertson,
May 2024,
In: Pharmacological Research
Date: May 2024
Telomere dysfunction in Tert knockout mice delays Braf<sup>V600E</sup>-induced melanoma development
Jinglong Zhang, Fan Zhang, Kenneth I. Porter, Panshak P. Dakup, Shuwen Wang, Gavin P. Robertson, Shobhan Gaddameedhi, Jiyue Zhu,
Feb 1 2024,
In: International Journal of Cancer
Date: Feb 1 2024
Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells
Weam Othman Elbezanti, Omar S. Al-Odat, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Krishne Gowda, Shantu Amin, Gavin P. Robertson, Venkatesh V. Nemmara, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey,
Sep 9 2022,
In: Frontiers in Pharmacology
Date: Sep 9 2022
Drug-Tolerant Persister Cells in Cancer Therapy Resistance
Pavan Kumar Dhanyamraju, Todd D. Schell, Shantu Amin, Gavin P. Robertson,
Jul 15 2022,
In: Cancer Research
Date: Jul 15 2022
Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Saketh S. Dinavahi, Yu Chi Chen, Kishore Punnath, Arthur Berg, Meenhard Herlyn, Momeneh Foroutan, Nicholas D. Huntington, Gavin P. Robertson,
Jun 2022,
In: Cancer Immunology Research
Date: Jun 2022
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
Joseph F. Costello, Michael C. Frühwald, Dominic J. Smiraglia, Laura J. Rush, Gavin P. Robertson, Xin Gao, Fred A. Wright, Jamison D. Feramisco, Päivi Peltomäki, James C. Lang, David E. Schuller, Li Yu, Clara D. Bloomfield, Michael A. Caligiuri, Allan Yates, Ryo Nishikawa, H. J. Su Huang, Nichola...,
Feb 2000,
In: Nature Genetics
Citations: 1,216
The role of cholesterol in cancer
Omer F. Kuzu, Mohammad A. Noory, Gavin P. Robertson,
Apr 15 2016,
In: Cancer Research
Citations: 611
Deregulated Akt3 activity promotes development of malignant melanoma
Jill M. Stahl, Arati Sharma, Mitchell Cheung, Melissa Zimmerman, Jin Q. Cheng, Marcus W. Bosenberg, Mark Kester, Lakshman Sandirasegarane, Gavin P. Robertson,
Oct 1 2004,
In: Cancer Research
Citations: 498
Suppression of BRAF<sup>V599E</sup> in human melanoma abrogates transformation
Sunil R. Hingorani, Michael A. Jacobetz, Gavin P. Robertson, Meenhard Herlyn, David A. Tuveson,
Sep 1 2003,
In: Cancer Research
Citations: 400
Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development
Sung Jin Huh, Shile Liang, Arati Sharma, Cheng Dong, Gavin P. Robertson,
Jul 15 2010,
In: Cancer Research
Citations: 324
Mutant <sup>V599E</sup>B-Raf regulates growth and vascular development of malignant melanoma tumors
Arati Sharma, Nishit R. Trivedi, Melissa A. Zimmerman, David A. Tuveson, Charles D. Smith, Gavin P. Robertson,
Mar 15 2005,
In: Cancer Research
Citations: 293
Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer Cells
Mark Kester, Yasser Heakal, Todd Fox, Arati Sharma, Gavin P. Robertson, Thomas T. Morgan, Erhan I. Altinoǧlu, Amra Tabaković, Mylisa R. Parette, Sarah M. Rouse, Victor Ruiz-Velasco, James H. Adair,
Dec 2008,
In: Nano letters
Citations: 251
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems
Arati Sharma, Subbarao V. Madhunapantula, Gavin P. Robertson,
Jan 2012,
In: Expert Opinion on Drug Metabolism and Toxicology
Citations: 222
Loss of PTEN promotes tumor development in malignant melanoma
Jill M. Stahl, Mitchell Cheung, Arati Sharma, Nishit R. Trivedi, Sumathi Shanmugam, Gavin Robertson,
Jun 1 2003,
In: Cancer Research
Citations: 217
Targeting the MAPK pathway in melanoma
Gajanan S. Inamdar, Subba Rao V. Madhunapantula, Gavin P. Robertson,
Sep 2010,
In: Biochemical Pharmacology
Citations: 197
